Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 373.85 INR 2.06% Market Closed
Market Cap: 46.1B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikal Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Total Current Liabilities
â‚ą7.6B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Current Liabilities
â‚ą129.2B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Current Liabilities
â‚ą54.5B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Current Liabilities
â‚ą172.5B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
16%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Current Liabilities
â‚ą48.5B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Current Liabilities
â‚ą21.2B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
46.1B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
268.95 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Total Current Liabilities?
Total Current Liabilities
7.6B INR

Based on the financial report for Sep 30, 2024, Hikal Ltd's Total Current Liabilities amounts to 7.6B INR.

What is Hikal Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
6%

Over the last year, the Total Current Liabilities growth was 8%. The average annual Total Current Liabilities growth rates for Hikal Ltd have been 4% over the past three years , 6% over the past five years .

Back to Top